151 related articles for article (PubMed ID: 27549171)
21. PARP-1 inhibition prevents CNS migration of dendritic cells during EAE, suppressing the encephalitogenic response and relapse severity.
Cavone L; Aldinucci A; Ballerini C; Biagioli T; Moroni F; Chiarugi A
Mult Scler; 2011 Jul; 17(7):794-807. PubMed ID: 21343230
[TBL] [Abstract][Full Text] [Related]
22. Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis.
Chen SJ; Huang SH; Chen JW; Wang KC; Yang YR; Liu PF; Lin GJ; Sytwu HK
Int Immunopharmacol; 2016 Feb; 31():169-77. PubMed ID: 26735612
[TBL] [Abstract][Full Text] [Related]
23. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
Jadidi-Niaragh F; Mirshafiey A
Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
[TBL] [Abstract][Full Text] [Related]
24. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
Shen R; Deng W; Li C; Zeng G
Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476
[TBL] [Abstract][Full Text] [Related]
25. Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Carbajal KS; Mironova Y; Ulrich-Lewis JT; Kulkarni D; Grifka-Walk HM; Huber AK; Shrager P; Giger RJ; Segal BM
J Immunol; 2015 Sep; 195(6):2552-9. PubMed ID: 26238492
[TBL] [Abstract][Full Text] [Related]
26. Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems.
Wang Y; Cao L; Xu LM; Cao FF; Peng B; Zhang X; Shen YF; Uzan G; Zhang DH
J Neuroimmune Pharmacol; 2015 Sep; 10(3):506-16. PubMed ID: 25773257
[TBL] [Abstract][Full Text] [Related]
27. The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
Takada I; Yogiashi Y; Makishima M
Immunobiology; 2016 Feb; 221(2):188-92. PubMed ID: 26386981
[TBL] [Abstract][Full Text] [Related]
28. Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.
Pardo E; Cárcamo C; Uribe-San Martín R; Ciampi E; Segovia-Miranda F; Curkovic-Peña C; Montecino F; Holmes C; Tichauer JE; Acuña E; Osorio-Barrios F; Castro M; Cortes P; Oyanadel C; Valenzuela DM; Pacheco R; Naves R; Soza A; González A
PLoS One; 2017; 12(6):e0177472. PubMed ID: 28650992
[TBL] [Abstract][Full Text] [Related]
29. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
Mondal S; Pahan K
PLoS One; 2015; 10(1):e0116566. PubMed ID: 25569428
[TBL] [Abstract][Full Text] [Related]
30. An aza-anthrapyrazole negatively regulates Th1 activity and suppresses experimental autoimmune encephalomyelitis.
Clark MP; Leaman DW; Hazelhurst LA; Hwang ES; Quinn A
Int Immunopharmacol; 2016 Feb; 31():74-87. PubMed ID: 26709219
[TBL] [Abstract][Full Text] [Related]
31. BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway.
You Z; Timilshina M; Jeong BS; Chang JH
Eur J Immunol; 2017 Sep; 47(9):1488-1500. PubMed ID: 28681958
[TBL] [Abstract][Full Text] [Related]
32. Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response.
Lowther DE; Chong DL; Ascough S; Ettorre A; Ingram RJ; Boyton RJ; Altmann DM
Acta Neuropathol; 2013 Oct; 126(4):501-15. PubMed ID: 23934116
[TBL] [Abstract][Full Text] [Related]
33. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
34. IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis.
Lee Y; Mitsdoerffer M; Xiao S; Gu G; Sobel RA; Kuchroo VK
J Clin Invest; 2015 Nov; 125(11):4011-20. PubMed ID: 26413871
[TBL] [Abstract][Full Text] [Related]
35. IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.
Luchtman DW; Ellwardt E; Larochelle C; Zipp F
Cytokine Growth Factor Rev; 2014 Aug; 25(4):403-13. PubMed ID: 25153998
[TBL] [Abstract][Full Text] [Related]
36. Lung inflammation stalls Th17-cell migration en route to the central nervous system during the development of experimental autoimmune encephalomyelitis.
Kanayama M; Danzaki K; He YW; Shinohara ML
Int Immunol; 2016 Sep; 28(9):463-9. PubMed ID: 26989091
[TBL] [Abstract][Full Text] [Related]
37. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
Lee J; Choi J; Lee W; Ko K; Kim S
Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
[TBL] [Abstract][Full Text] [Related]
38. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
[TBL] [Abstract][Full Text] [Related]
39. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
[TBL] [Abstract][Full Text] [Related]
40. Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4.
Glatigny S; Duhen R; Arbelaez C; Kumari S; Bettelli E
Sci Rep; 2015 Jan; 5():7834. PubMed ID: 25592296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
